DRUG-TREATMENT OF PRIMARY HYPERLIPOPROTEINEMIA

被引：13

作者：

KLOSE, G

MORDASINI, R

MIDDELHOFF, G

AUGUSTIN, J

GRETEN, H

机构：

来源：

KLINISCHE WOCHENSCHRIFT | 1978年 / 56卷 / 03期

关键词：

D O I：

10.1007/BF01478565

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：99 / 110

页数：12

共 152 条

[51] TREATMENT OF HYPERLIPOPROTEINEMIA TYPE-IIA WITH A NEW ANION-EXCHANGE RESIN SECHOLEX [J].

GUSTAFSON, A ;

LANNER, A .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (01) :65-69

[52]

HAVEL JR, 1972, ARCH EXP BIOL MED, V26, P57

[53] REDUCTION OF CHOLESTEROL AND LIPIDS IN MAN BY ETHYL P-CHLOROPHENOXYISOBUTYRATE [J].

HELLMAN, L ;

RUBIN, IL ;

KESSLER, G ;

KARA, E ;

ROSENFELD, RS ;

ZUMOFF, B .

ANNALS OF INTERNAL MEDICINE, 1963, 59 (04) :477-+

[54]

HERNANDEZ A, 1975, THERAPIEWOCHE, V25, P36

[55] SECHOLEX, CLOFIBRATE AND TAURINE IN HYPERLIPIDEMIA [J].

HOWARD, AN ;

COURTENA.RJ .

ATHEROSCLEROSIS, 1974, 20 (01) :105-116

[56] COMBINED USE OF CLOFIBRATE AND CHOLESTYRAMINE OR DEAE SPEHADEX IN HYPERCHOLESTEROLAEMIA [J].

HOWARD, AN ;

HYAMS, DE .

BRITISH MEDICAL JOURNAL, 1971, 3 (5765) :25-&

[57]

HOWARD AN, 1972, PHOSPHOLIPIDS BIOCHE, P79

[58] EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE, ALONE OR WITH ANDROSTERONE (ATROMID) ON SERUM LIPIDS, LIPOPROTEINS AND RELATED METABOLIC PARAMETERS IN NORMAL AND HYPERLIPIDEMIC SUBJECTS [J].

HOWARD, RP ;

ALAUPOVIC, P ;

BRUSCO, OJ ;

FURMAN, RH .

JOURNAL OF ATHEROSCLEROSIS RESEARCH, 1963, 3 (5-6) :482-499

[59]

HOWARD RP, 1966, J LAB CLIN MED, V68, P12

[60] FACTORS OF RISK IN DEVELOPMENT OF CORONARY HEART DISEASE - 6-YEAR FOLLOW-UP EXPERIENCE [J].

KANNEL, WB ;

KAGAN, A ;

STOKES, J ;

DAWBER, TR ;

REVOTSKIE, N .

ANNALS OF INTERNAL MEDICINE, 1961, 55 (01) :33-+

← 1 2 3 4 5 6 7 8 9 10 →